Company intelligence / Profile preview

KBio

United Kingdomkbio.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

KBio leverages its proprietary RP3 platform to rapidly develop high-purity antibody therapies and vaccines using plants. The company claims its approach enables faster progression to clinical studies compared to industry norms, with demonstrated ability to produce novel drug candidates at lower cost. Its pipeline includes both preclinical and early-stage clinical programs targeting rare diseases, infectious disease threats, and pandemic preparedness.

Therapeutic areas
Rare DiseasesInfectious Diseases
Modalities
Antibodies (including monoclonal antibodies)VaccinesRecombinant proteins and bioactive compounds produced via plant expression systems
Industry
Biotech
02

Drug pipeline

6 assets

EV68-228-N

1

5 more assets in the full pipeline.

Request access →
03

Partnerships

Strategic global partnerships for technology optimization; specific partners not named publicly but includes collaboration with Kentucky BioProcessing Inc.

Beyond the preview

Go deeper on KBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KBio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call